Table 3.
Rates of complete or partial effectiveness at week 4 (LOCF)
| DE after a meal | Pantoprazole | |||
|---|---|---|---|---|
| Number of patients [n (%)] | 59 (100.0) | 58 (100.0) | ||
| Number (%) with complete or partial effectivenessa | 40 (67.8) | 50 (86.2) | ||
| 95% CI (%)b | (54.4, 79.4) | (74.6, 93.9) | ||
| Comparison versus DE after a meal | ||||
| Estimate | 18.41 | |||
| 95% CI (%)b | (0.71, 35.98) | |||
| p valuec | 0.0273 | |||
CI confidence interval, DE dabigatran etexilate, GIS gastrointestinal symptom, LOCF last observation carried forward
aComplete effectiveness is defined as all primary GIS and secondary GIS are resolved; partial effectiveness is defined as either primary GIS is improved; or primary GIS is resolved, but there were still unresolved secondary GIS. LOCF last observation carried forward
bExact 95% CI by Clopper and Pearson
c p value obtained from Exact test